Why should we care about fly tumors?: The case of JAK-STAT and EGFR cooperation in oncogenesis

James Castelli-Gair Hombría1, Florenci Serras

  • 1CABD (CSIC/JA/UPO); Universidad Pablo de Olavide; Seville, Spain.

JAK-STAT
|September 24, 2013
PubMed

Insights

Drosophila models reveal how combined EGFR and JAK-STAT signaling drives aggressive tumors. Tissue damage and pathway regulator changes are key to tumor growth and spread.

Area of Science:

  • Developmental biology
  • Cancer research
  • Signal transduction

Background:

  • The fruit fly Drosophila melanogaster serves as a powerful model organism for investigating complex biological processes.
  • Aggressive tumor formation is often linked to dysregulated signaling pathways.
  • Epidermal Growth Factor Receptor (EGFR) and Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) pathways are crucial in development and implicated in cancer.

Purpose of the Study:

  • To summarize recent findings on Drosophila models of aggressive tumors.
  • To elucidate the roles of EGFR and JAK-STAT signaling in tumor progression and metastasis.
  • To highlight the impact of tissue damage and pathway regulator modulation.

Main Methods:

  • Utilizing Drosophila melanogaster as a model system.
  • Investigating the genetic and molecular mechanisms underlying tumor formation.
  • Analyzing the interplay between tissue damage responses and oncogenic signaling pathways.

Main Results:

  • Combined activation of EGFR and JAK-STAT signaling in Drosophila induces aggressive tumor phenotypes.
  • Tissue damage acts as a significant factor promoting tumor progression and metastasis.
  • Modulation of common pathway regulators influences the severity of tumor growth and spread.

Conclusions:

  • Drosophila is a valuable model for studying aggressive cancers driven by EGFR and JAK-STAT.
  • Tissue damage and altered pathway regulators are critical drivers of tumor progression and metastasis in this model.
  • Findings provide insights into potential therapeutic targets for aggressive tumors.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...